Aytu Biopharma, Inc.

CO · United States · Reporting entity ID 100000151699

Total reported 2019–2025

$533K

#1,545 of 2,960 reporting companies — 0% of all reported industry payments

$452K in general payments across 10,658 records, plus $81K in research funding across 14 records.

How it breaks down

General payments $452,088

Research funding $80,613

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.